Economides Vassiliki 4
4 · Kezar Life Sciences, Inc. · Filed Feb 5, 2020
Insider Transaction Report
Form 4
Economides Vassiliki
SVP, Strategy & External Aff.
Transactions
- Purchase
Common Stock
2020-02-04$2.60/sh+5,769$14,999→ 7,570 total
Footnotes (1)
- [F1]Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.